Krüppel-like factor 4 functions as a tumor suppressor in cervical carcinoma

Cancer

Volumn 118, Issue 15, 2012, Pages 3691-3702

  Yang, Wen Ting ^a   Zheng, Peng Sheng ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

cervical carcinoma; KLF4; p27 Kip1; proliferation; tumor suppressor

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; KRUPPEL LIKE FACTOR 4; NUCLEOTIDE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TISSUE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN C33A; CELL STRAIN SIHA; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; UPREGULATION; UTERINE CERVIX CARCINOMA IN SITU; WESTERN BLOTTING;

CELL CYCLE; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; UTERINE CERVICAL NEOPLASMS;

EID: 84864151293     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26698     Document Type: Article

References (46)

1. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348: 518-527.
2. zur Hausen H,. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002; 2: 342-350.
3. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ,. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol. 2006; 208: 152-164.
4. Heselmeyer K, Schrock E, du Manoir S, et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci U S A. 1996; 93: 479-484.
5. Heselmeyer K, Macville M, Schrock E, et al. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer. 1997; 19: 233-240.
6. Narayan G, Pulido HA, Koul S, et al. Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression. Oncogene. 2003; 22: 3489-3499.
7. Dong SM, Kim HS, Rha SH, Sidransky D,. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res. 2001; 7: 1982-1986.
8. Narayan G, Scotto L, Neelakantan V, et al. Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer. Genes Chromosomes Cancer. 2009; 48: 983-992.
9. Narayan G, Arias-Pulido H, Koul S, et al. Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer. 2003; 2: 24.
10. Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF,. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res. 2001; 7: 584-589.
11. Segre JA, Bauer C, Fuchs E,. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet. 1999; 22: 356-360.
12. Katz JP, Perreault N, Goldstein BG, et al. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development. 2002; 129: 2619-2628.
13. Foster KW, Liu Z, Nail CD, et al. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene. 2005; 24: 1491-1500.
14. Takahashi K, Yamanaka S,. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663-676.
15. Wong CW, Hou PS, Tseng SF, et al. Kruppel-like transcription factor 4 contributes to maintenance of telomerase activity in stem cells. Stem Cells. 2010; 28: 1510-1517.
16. Yoon HS, Yang VW,. Requirement of Kruppel-like factor 4 in preventing entry into mitosis following DNA damage. J Biol Chem. 2004; 279: 5035-5041.
17. Chen ZY, Wang X, Zhou Y, Offner G, Tseng CC,. Destabilization of Kruppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway. Cancer Res. 2005; 65: 10394-10400.
18. Chen X, Whitney EM, Gao SY, Yang VW,. Transcriptional profiling of Kruppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation. J Mol Biol. 2003; 326: 665-677.
19. Dang DT, Chen X, Feng J, Torbenson M, Dang LH, Yang VW,. Overexpression of Kruppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecity. Oncogene. 2003; 22: 3424-3430.
20. Yoon HS, Chen X, Yang VW,. Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J Biol Chem. 2003; 278: 2101-2105.
21. Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE, Yang VW,. Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene. 2004; 23: 395-402.
22. Wei D, Kanai M, Jia Z, Le X, Xie K,. Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res. 2008; 68: 4631-4639.
23. Wei D, Gong W, Kanai M, et al. Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 2005; 65: 2746-2754.
24. Ohnishi S, Ohnami S, Laub F, et al. Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem Biophys Res Commun. 2003; 308: 251-256.
25. Katz JP, Perreault N, Goldstein BG, et al. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology. 2005; 128: 935-945.
26. Pandya AY, Talley LI, Frost AR, et al. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res. 2004; 10: 2709-2719.
27. Rowland BD, Bernards R, Peeper DS,. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol. 2005; 7: 1074-1082.
28. Rowland BD, Peeper DS,. KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer. 2006; 6: 11-23.
29. Tai SK, Yang MH, Chang SY, et al. Persistent Kruppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma. Cancer Sci. 2011; 102: 895-902.
30. Wang L, Wei D, Huang S, et al. Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res. 2003; 9: 6371-6380.
31. Minami S, Ohtani-Fujita N, Igata E, Tamaki T, Sakai T,. Molecular cloning and characterization of the human p27Kip1 gene promoter. FEBS Lett. 1997; 411: 1-6.
32. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 2007; 21: 525-530.
33. Villarreal G Jr, Zhang Y, Larman HB, Gracia-Sancho J, Koo A, Garcia-Cardena G,. Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells. Biochem Biophys Res Commun. 2010; 391: 984-989.
34. Ehlermann J, Pfisterer P, Schorle H,. Dynamic expression of Kruppel-like factor 4 (Klf4), a target of transcription factor AP-2alpha during murine mid-embryogenesis. Anat Rec A Discov Mol Cell Evol Biol. 2003; 273: 677-680.
35. Foster KW, Frost AR, McKie-Bell P, et al. Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res. 2000; 60: 6488-6495.
36. Foster KW, Ren S, Louro ID, et al. Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ. 1999; 10: 423-434.
37. Chen X, Johns DC, Geiman DE, et al. Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J Biol Chem. 2001; 276: 30423-30428.
38. Schoell WM, Janicek MF, Mirhashemi R,. Epidemiology and biology of cervical cancer. Semin Surg Oncol. 1999; 16: 203-211.
39. Cain JM, Howett MK,. Preventing cervical cancer. Science. 2000; 288: 1753-1755.
40. Brembeck FH, Rustgi AK,. The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 and Sp1. J Biol Chem. 2000; 275: 28230-28239.
41. Brembeck FH, Moffett J, Wang TC, Rustgi AK,. The keratin 19 promoter is potent for cell-specific targeting of genes in transgenic mice. Gastroenterology. 2001; 120: 1720-1728.
42. Wei D, Kanai M, Huang S, Xie K,. Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis. 2006; 27: 23-31.
43. Ghaleb AM, Katz JP, Kaestner KH, Du JX, Yang VW,. Kruppel-like factor 4 exhibits antiapoptotic activity following gamma-radiation-induced DNA damage. Oncogene. 2007; 26: 2365-2373.
44. Zhang W, Geiman DE, Shields JM, et al. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem. 2000; 275: 18391-18398.
45. Shie JL, Chen ZY, Fu M, Pestell RG, Tseng CC,. Gut-enriched Kruppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res. 2000; 28: 2969-2976.
46. Kiyokawa H, Kineman RD, Manova-Todorova KO, et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell. 1996; 85: 721-732.